SCHEMBL26857074

SCHEMBL26857074

N#Cc1cccc(CNC(=O)c2cc(-c3ccc4nc(N)nn4c3)cs2)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 3/20 0.43
▸ MMP12 P39900 2/20 0.41
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ KLKB1 P03952 3/20 0.40
▸ ADORA2A P29274 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ CHRM3 P20309 1/20 0.37
▸ KLK1 P06870 1/20 0.37
▸ ROCK2 O75116 3/20 0.37
▸ AOC3 Q16853 1/20 0.37
▸ ERCC1 P07992 1/20 0.37
▸ ERCC4 Q92889 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ GLS O94925 1/20 0.36
▸ TGFBR1 P36897 2/20 0.36
▸ MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26856882 0.87 MMP12 (0.53) TTKMMP12PIK3CDPIK3CGADORA2A
SCHEMBL26856949 0.87 MAPK1 (0.47) MMP12PIK3CDPIK3CGADORA2AADORA1
SCHEMBL26856951 0.87 ADORA2A (0.43) TTKMMP12PIK3CDPIK3CGADORA2A
SCHEMBL26857017 0.87 MAPK1 (0.46) TTKMMP12PIK3CDPIK3CGADORA2A
SCHEMBL26857184 0.86 MMP12 (0.44) TTKMMP12PIK3CDPIK3CGROCK2
SCHEMBL26856914 0.84 MAPK1 (0.49) PIK3CGADORA2AADORA1MMP13ROCK2
SCHEMBL26857172 0.84 MMP12 (0.40) TTKMMP12PIK3CDPIK3CGCHRM3
SCHEMBL26856987 0.83 PIK3CG (0.46) MMP12PIK3CDPIK3CGADORA2AADORA1
SCHEMBL26856955 0.83 ROCK1 (0.46) TTKMMP12PIK3CDPIK3CGADORA2A
SCHEMBL26857044 0.82 MMP12 (0.42) TTKMMP12PIK3CDPIK3CGROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 TTK 2266/4885MMP12 4866/4885PIK3CD 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback